Head-to-head · computed 2026-08-11
Direct Meds vs Noom Med
Direct Meds: Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery. Noom Med: Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in.
Tirzepatide
| Direct Meds | Noom Med | |
|---|---|---|
| All-in maintenance | $399/mo | $299/mo |
| Best plan rate | $399/mo | $299/mo |
| 12-month total | $4,788 | $3,588 |
| Status | Reported · 2026-07-25 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Noom Med's $299 a month undercuts Direct Meds's $399 by $100 a month at the 10 mg/wk maintenance basis — $1,200 across a year. Noom Med's figure is reported (captured 2026-08-11) and Direct Meds's is reported (captured 2026-07-25); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Direct Meds's tirzepatide ladder runs $399 a month billed monthly. Noom Med's runs $299 a month billed monthly. On the twelve-month basis Noom Med's $3,588 beats Direct Meds's $4,788 by $1,200 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Direct Meds | Noom Med | |
|---|---|---|
| All-in maintenance | $297/mo | $249/mo |
| Best plan rate | $297/mo | $249/mo |
| 12-month total | $3,564 | $2,988 |
| Status | Reported · 2026-07-25 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Noom Med's $249 a month undercuts Direct Meds's $297 by $48 a month at the 2.4 mg/wk maintenance basis — $576 across a year. Noom Med's figure is reported (captured 2026-08-11) and Direct Meds's is reported (captured 2026-07-25); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Direct Meds's semaglutide ladder runs $297 a month billed monthly. Noom Med's runs $249 a month billed monthly. On the twelve-month basis Noom Med's $2,988 beats Direct Meds's $3,564 by $576 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, Noom Med is dose-flat — the price survives titration — while Direct Meds's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Direct Meds
- MembershipNone
- Dose policyAll-inclusive per format; injection and sublingual priced separately
- CommitmentMonthly (no commitment indicated)
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
Noom Med
- MembershipNone
- Dose policyFlat at published rate
- CommitmentProgram-based
- CancellationPer plan terms
- PharmacyPartner pharmacies
What our desk is watching on each
Direct Meds: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.
Noom Med: Basis correction on record: the $199 figure previously recorded reflects Noom's microdose tier, which caps at 0.6 mg and therefore fails this site's maintenance-dose comparison basis; the standard compounded tiers — $249/mo semaglutide, $299/mo GLP-1/GIP Plus (tirzepatide) — are the rankable figures. Microdose tiers ($179 semaglutide / $199 tirzepatide per Noom's July 27, 2026 pricing) exist for gentler entry. All plans bill quarterly, not monthly; the branded-medication track ($99/mo after a $149 first month, medication separate) is a different product. Compounded not available in all states per Noom's own materials.
Questions people ask
Is Direct Meds or Noom Med cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Direct Meds vs Noom Med miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Direct Meds and Noom Med cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,788 at Direct Meds and $3,588 at Noom Med — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Direct Meds · Noom Med. Official sites: Direct Meds ↗ · Noom Med ↗. Nothing here is medical advice.